日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical, pathological, and prognostic features of invasive pyelocaliceal urothelial carcinoma with venous thrombus: A propensity score-matched retrospective cohort study

伴有静脉血栓的浸润性肾盂肾盏尿路上皮癌的临床、病理和预后特征:一项倾向评分匹配的回顾性队列研究

Zhang, Zhanyi; Deng, Shaohui; Zhang, Yu; Xie, Ruiyang; Lu, Min; Song, Yimeng; Sun, Yuehao; Ma, LuLin; Zhang, Hongxian; Zhang, Shudong

The influence of CRS and ICANS on the efficacy of anti-CD19 CAR-T treatment for B-cell acute lymphoblastic leukemia.

CRS 和 ICAN 对抗 CD19 CAR-T 治疗 B 细胞急性淋巴细胞白血病疗效的影响

Ma Yuhan, Zhou Hongyuan, Zhang Jiaoli, Zhang Qing, Li Yujie, Xie Ruiyang, Zhang Bingpei, Shen Ziyuan, Li Ping, Liang Aibin, Zhou Keshu, Han Lu, Hu Yongxian, Xu Kailin, Sang Wei, Wang Xiangmin

Dynamic Changes in Serum Immunoglobulin G Predict Clinical Response and Prognosis in Metastatic Clear-cell Renal Cell Carcinoma

血清免疫球蛋白G的动态变化可预测转移性透明细胞肾细胞癌的临床反应和预后

Cui, Honglei; Wu, Jie; Du, Gan; Hu, Linjun; Dong, Xin; Qu, Wang; Bai, Hongsong; Shang, Bingqing; Xie, Ruiyang; Shi, Hongzhe; Guan, Youyan; Bi, Xingang; Li, Changling; Ma, Jianhui; Zhou, Aiping; Shou, Jianzhong

Efficacy and safety of systemic treatment for progressive and refractory desmoid tumor: a systematic review and Bayesian network meta-analysis

系统治疗进展性难治性纤维瘤的疗效和安全性:系统评价和贝叶斯网络荟萃分析

Ou, Junyong; Su, Dandan; Guan, Yunhe; Ge, Liyuan; Deng, Shaohui; Yan, Ye; Hao, Yichang; Lu, Min; Zhang, Shudong; Xie, Ruiyang

Neutrophil extracellular traps primed intercellular communication in cancer progression as a promising therapeutic target

中性粒细胞胞外陷阱促进癌症进展中的细胞间通讯,是一种有前景的治疗靶点

Shang, Bingqing; Cui, Honglei; Xie, Ruiyang; Wu, Jie; Shi, Hongzhe; Bi, Xingang; Feng, Lin; Shou, Jianzhong

Hematologic side effects of immune checkpoint inhibitor with or without chemotherapy in patients with advanced and metastatic gastrointestinal cancer: A systematic review and network meta-analysis of phase 3 trials

免疫检查点抑制剂联合或不联合化疗治疗晚期和转移性胃肠道癌症患者的血液学副作用:一项3期临床试验的系统评价和网络荟萃分析

Hou, Jingyi; Xie, Ruiyang; Zhang, Zhuo; Liu, Qianxin; Xiang, Qian; Cui, Yimin

Optimizing targeted drug selection in combination therapy for patients with advanced or metastatic renal cell carcinoma: A systematic review and network meta-analysis of safety

优化晚期或转移性肾细胞癌患者联合治疗中靶向药物的选择:一项安全性系统评价和网络荟萃分析

Xie, Ruiyang; Wu, Jie; Shang, Bingqing; Bi, Xingang; Jiang, Weixing; Cao, Chuanzhen; Zhou, Aiping; Shi, Hongzhe; Shou, Jianzhong

A novel nomogram can predict pathological T3a upstaged from clinical T1a in localized renal cell carcinoma

一种新型列线图可以预测局限性肾细胞癌中由临床T1a期升级为病理T3a期的病变。

Cao, Chuanzhen; Kang, Xiangpeng; Shang, Bingqing; Shou, Jianzhong; Shi, Hongzhe; Jiang, Weixing; Xie, Ruiyang; Zhang, Jin; Zhang, Lianyu; Zheng, Shan; Bi, Xingang; Li, Changling; Ma, Jianhui

Novel cut-off values of time from diagnosis to systematic therapy predict the overall survival and the efficacy of targeted therapy in renal cell carcinoma: A long-term, follow-up, retrospective study

诊断至系统治疗时间的新临界值可预测肾细胞癌患者的总生存期和靶向治疗疗效:一项长期随访回顾性研究

Cao, Chuanzhen; Shou, Jianzhong; Shi, Hongzhe; Jiang, Weixing; Kang, Xiangpeng; Xie, Ruiyang; Shang, Bingqing; Bi, Xingang; Zhang, Jin; Zheng, Shan; Zhou, Aiping; Li, Changling; Ma, Jianhui

Deaths and adverse events from adjuvant therapy with immune checkpoint inhibitors in solid malignant tumors: A systematic review and network meta-analysis

实体恶性肿瘤辅助治疗中免疫检查点抑制剂的死亡和不良事件:系统评价和网络荟萃分析

Xie, Ruiyang; Wu, Jie; Shang, Bingqing; Bi, Xingang; Cao, Chuanzhen; Guan, Youyan; Shi, Hongzhe; Shou, Jianzhong